Tudor Investment Corp
DNA icon

Tudor Investment Corp’s Ginkgo Bioworks DNA Stock Holding History

Tudor Investment Corp’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.85M Buy
464,663
+270,701
+140% +$2.25M 0.01% 1588
2025
Q4 		$1.61M Buy
+193,962
New +$2.09M ﹤0.01% 1967
2025
Q2 		– Sell
-68,327
Closed -$389K – 3356
2025
Q1 		$389K Buy
+68,327
New +$696K ﹤0.01% 2437
2024
Q3 		– Sell
-1,090
Closed -$14.6K – 2789
2024
Q2 		$14.6K Buy
+1,090
New +$32.5K ﹤0.01% 2248
2023
Q1 		– Sell
-2,523
Closed -$171K – 2529
2022
Q4 		$171K Buy
+2,523
New +$232K ﹤0.01% 2159
2022
Q2 		– Sell
-1,831
Closed -$223K – 2198
2022
Q1 		$295K Buy
+1,831
New +$356K 0.01% 1565

Other funds holding DNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.18B AUM 27.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return